The Nebraska Medical Center

Oncology Service Line Cancer treatment services offered by the corporation include treatment of lymphoma, leukemia, multiple myeloma, head and neck, breast, gastrointestinal, pancreatic, lung, genitourinary prostate, gynecologic, melanoma, brain, and spine cancers. The patients are supported by research that is conducted on the University of Nebraska Medical Center (UNMC) campus. The Nebraska Medical Center (TNMC) is the only clinical cancer center in its service area designated by the national cancer institute. In addition to treatment and clinical trials, TNMC offers support groups, social work, pain management, financial counselors, survivorship groups, genetic counseling, and a variety of additional patient supportive services. In June 2017, TNMC opened the Fred and Pamela Buffett Cancer Center. The center is jointly owned with UNMC, and it is one of the foremost cancer research and treatment facilities in the country. It is the site of inpatient hospital care, as well as outpatient and diagnostic care. UNMC's facilities, within the center, house research labs. TNMC operates cancer treatment locations in Bellevue, NE; West Omaha, NE; Rural Central Nebraska; and Atlantic, IA. In addition, as one of the busiest programs in the world, the bone marrow transplantation program served 234 patients in the year ended June 30, 2023. A 24/7 emergency and evaluation treatment center are dedicated to cancer and transplants. The program benefits from the research conducted on TNMC/UNMC campuses. TNMC was one of the first cancer centers in the nation to participate in clinical trials for CAR-T cell therapy. It was FDA-Approved in October 2017. The therapy treatment was extended to leukemia patients in 2018 and multiple myeloma patients in 2019. During fiscal year 2023, the oncology service line treated 138,228 cases.

Heart and Vascular Service Line The Nebraska Medical Center (TNMC) provides a wide range of cardiovascular services from diet counseling to surgical procedures and rehabilitation to patients from the surrounding region. TNMC has grown into one of the busiest centers in the country for ventricular assist device operations. TNMC has been successful in recruiting physicians and has the only heart failure specialist in the region, and the only heart failure program certified by the joint commission in the State of Nebraska. In 2016, TNMC began a lung transplant program, and in December 2017, TNMC performed the state's first heart and lung transplant. In the year ended June 30, 2023, TNMC performed 7 lung transplants. The congestive heart failure program and acute myocardial infarction program each received the gold seal of approval certification from the American Heart Association. This program is certified by the joint commission, and these services are the only nationally certified programs of their kind in the State of Nebraska. The chest pain center has received full chest pain center accreditation from the Society of Chest Pain Centers. TNMC has been recognized for service excellence under the J.D. Power and Associates Distinguished Hospital Program. TNMC has the only joint commission certified destination therapy program in the state and is the only hospital in the region performing adult heart transplants and implanting total artificial hearts. In the year ended June 30, 2023, 878 open heart surgeries were performed, including 34 heart transplants.